Trichuriasis Clinical Trial
Official title:
Longitudinal Study of Efficacy of Standard Albendazole Treatment Versus Levamisole/Pyrantel Pamoate on Soil Transmitted Helminth Infections
Field epidemiological studies undertaken during 2005 in four village locations in Northern
Unguja, Zanzibar examined mothers and their pre-school aged children for helminth
infections.
The prevalence of Ascaris lumbricoides was found to have remained relatively high despite
community-wide treatment with the mass administration of Albendazole (a WHO recommended
de-wormer) in coordination with community vitamin A supplementation.
One hypothesis for this is that the children and mothers had Ascaris infections more
tolerant to Albendazole that subsequently failed to clear. It is necessary to compare the
present drug efficiency of Albendazole (first-line de-wormer) with Levamisole (second-line
de-wormer) on STH infections such patients a case-control setting to shed light on the
putative resistance of local Ascaris/Trichuris to albendazole.
In so doing, this should clarify whether there is resistance developing towards Albendazole
and have possible implications for introducing combination therapies of Levamisole and
Albendazole for first line de-worming mothers and their children in the future.
The study was conducted in 10 villages on Unguja Island representative of urban, semi-urban
and rural environments. After liaison with the local Shehia (the elected community leader)
mothers and their children aged between 6 months and 5 years old were invited to attend a
walk-in mobile clinic. In accordance with WHO sample size recommendations of 30 individuals
per site and to cater for drop-out/non-compliance, target enrolment was about 50 mother and
child pairs at each study village.
Stool specimens were transported to the Helmtin Control Laboratory Unguja laboratory for
visual inspection of stool consistency and presence of blood, after which a single Kato-Katz
thick smear (41.7mg) was prepared. Eggs of all STH species were counted by inspection at
100x microscopy and expressed as a tally of eggs per gram (EPG). To ensure consistency of
egg counts, slides were read by the same two technicians for each study village.
10 Mother and child pairs found positive for Ascaris and/or Trichuris were randomised, by
coin tossing, to receive either a single tablet of ALB (400mg) or an appropriate dose of LEV
(2.5 mg/kg). A parasitological follow-up took place 18 days after treatment where a
requested stool sample was analyzed by a single Kato-Katz thick smear for assessment of STH
clearance. In accordance with WHO's 'no survey without service' all attendees were given an
additional ALB tablet.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03527732 -
Efficacy and Safety of IVM/ALB Co-administration
|
Phase 2/Phase 3 | |
Completed |
NCT06037876 -
Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura
|
Phase 3 | |
Completed |
NCT03527745 -
Albendazole Dose Finding and Pharmacokinetics in Children and Adults
|
Phase 2 | |
Not yet recruiting |
NCT04713787 -
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
|
Phase 2 | |
Active, not recruiting |
NCT06188715 -
Efficacy and Safety of MOX/ALB Co-administration in SAC
|
Phase 3 | |
Completed |
NCT04700423 -
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
|
Phase 2/Phase 3 | |
Recruiting |
NCT06184399 -
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
|
Phase 2 | |
Completed |
NCT04726969 -
Efficacy and Safety of MOX/ALB Co-administration
|
Phase 3 | |
Not yet recruiting |
NCT05706116 -
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
|
Phase 1 | |
Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A |